全文获取类型
收费全文 | 65989篇 |
免费 | 5687篇 |
国内免费 | 3550篇 |
专业分类
耳鼻咽喉 | 601篇 |
儿科学 | 1077篇 |
妇产科学 | 829篇 |
基础医学 | 7799篇 |
口腔科学 | 933篇 |
临床医学 | 7963篇 |
内科学 | 10813篇 |
皮肤病学 | 890篇 |
神经病学 | 4104篇 |
特种医学 | 2753篇 |
外国民族医学 | 19篇 |
外科学 | 7104篇 |
综合类 | 8956篇 |
现状与发展 | 14篇 |
一般理论 | 13篇 |
预防医学 | 4777篇 |
眼科学 | 1535篇 |
药学 | 6671篇 |
52篇 | |
中国医学 | 2842篇 |
肿瘤学 | 5481篇 |
出版年
2024年 | 171篇 |
2023年 | 870篇 |
2022年 | 2145篇 |
2021年 | 3029篇 |
2020年 | 2166篇 |
2019年 | 2094篇 |
2018年 | 2221篇 |
2017年 | 1967篇 |
2016年 | 2124篇 |
2015年 | 2922篇 |
2014年 | 3559篇 |
2013年 | 3753篇 |
2012年 | 5448篇 |
2011年 | 5683篇 |
2010年 | 3898篇 |
2009年 | 3052篇 |
2008年 | 3946篇 |
2007年 | 3934篇 |
2006年 | 3514篇 |
2005年 | 3445篇 |
2004年 | 2663篇 |
2003年 | 2634篇 |
2002年 | 2241篇 |
2001年 | 1375篇 |
2000年 | 1066篇 |
1999年 | 1020篇 |
1998年 | 645篇 |
1997年 | 623篇 |
1996年 | 416篇 |
1995年 | 459篇 |
1994年 | 348篇 |
1993年 | 215篇 |
1992年 | 293篇 |
1991年 | 214篇 |
1990年 | 182篇 |
1989年 | 184篇 |
1988年 | 126篇 |
1987年 | 132篇 |
1986年 | 128篇 |
1985年 | 65篇 |
1984年 | 43篇 |
1983年 | 33篇 |
1982年 | 31篇 |
1981年 | 21篇 |
1980年 | 18篇 |
1979年 | 19篇 |
1977年 | 9篇 |
1973年 | 13篇 |
1972年 | 11篇 |
1969年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
包皮过长和包茎组织中触觉小体观察 总被引:5,自引:2,他引:3
目的观察包茎和包皮过长组织中触觉小体差异情况。方法收集21~25岁年龄组包皮标本44例,按包皮解剖形态分为:①包茎组21例;②包皮过长组23例。用免疫组化方法对两组包皮标本中的触觉小体进行染色,在放大100倍的视野下观察和统计两组包皮标本中触觉小体总数以及视野的总数,并用卡方检验对两组间的差异进行统计学分析。结果两组标本中,分别有8个(8/21包茎组)和10个(10/23包皮过长组)标本中未发现触觉小体,其差异无显著性(P=0.717)。包茎组和包皮过长组中触觉小体的密度分别为33.1%和21.1%,差异具显著性(P=0.022)。结论包茎中触觉小体密度较包皮过长明显升高可能是一种生理性代偿机制,而两种包皮组织中触觉小体的消失可能遵循同一规律。 相似文献
22.
23.
24.
四氧嘧啶诱发糖尿病大鼠血管紧张素的变化 总被引:1,自引:0,他引:1
实验观察了四氧嘧啶诱发糖尿病大鼠连续饲养110d后体内肾素一血管紧张素系统的变化。结果表明,血浆和心脏的血管紧张素Ⅱ含量无明显变化,而肾脏的AngⅡ含量却明显低于正常对照组。另外,心脏的心钠素(ANP)含量在糖尿病大鼠与正常对照组之间无差别,血中的糖化血红蛋白含量基本无变化。上述结果表明,糖尿病大鼠早期心脏可能无明显损伤,而肾脏的肾素一血管紧张素系统活性降低。 相似文献
25.
26.
原发性小肠恶性肿瘤的CT诊断 总被引:15,自引:0,他引:15
本文回顾性分析34例经病理证实的原发性小肠恶性肿瘤的CT表现。病变包括腺癌16例,平滑肌肉瘤12例,淋巴瘤6例。CT扫描能明确肿瘤向腔内和腔外侵犯的程度,清晰显示肿瘤与邻近结构的关系,有无局部及远处转移等,为临床治疗提供帮助。鉴别诊断应包括小肠良性肿瘤、炎性病变和转移性肿瘤等。 相似文献
27.
B J Dong 《American journal of hospital pharmacy》1990,47(2):356-361
The patient-care activities of a pharmacist in a thyroid clinic are described. Since 1978 a pharmacist has been an active member of the staff of a thyroid clinic associated with a 500-bed university hospital. More than 1500 patients are referred to the clinic each year. The pharmacist initiates, maintains, or modifies the drug therapy of selected patients with physician-diagnosed thyroid disorders under the guidance of written protocols approved by the chief endocrinologist. Most patients treated by the pharmacist are receiving thyroid-suppression therapy, antithyroid drugs for Graves' disease, or thyroid hormone supplementation after surgery or after radioactive iodine therapy. The pharmacist assesses patients, prescribes medications, orders laboratory tests, charts visits and therapeutic plans, and educates patients about their conditions. Major changes in thyroid status and drug therapy are always discussed with the chief endocrinologist. The pharmacist also participates in educational programs to influence prescribing by physicians, provides drug information, serves as a preceptor to pharmacy students, and is investigating the equivalence of levothyroxine preparations in vivo and in vitro. An audit of patient outcomes showed that the pharmacist is highly effective in her role as a giver of direct patient care. A pharmacist's role in a thyroid clinic can consist of clinical practice, education, preceptorship, and research. 相似文献
28.
Hea-Young P. Choo Hea-Ran Yoon Hwha-Soon Park Dong-Hyun Kim Jongsei Park Dong H. Kim 《Archives of pharmacal research》1998,21(2):168-173
The epoxyalkanoyl derivatives were designed and synthesized as ACE inhibitors. Coupling of unsaturated carboxylic acids with amino acids and following epoxidation with dimethyldioxirane gave the epoxyalkanoyls with high yield. The inhibitory activity of synthesized compounds on angiotensin converting enzyme was IC50 values of 0.06≈5.5 μM. 相似文献
29.
Dr. D. Byron May Pharm.D.M Dr. Richard H. Drew M.S. Dr. Kimberly C. Yedinak Pharm.D. Dr. John A. Bartlett M.D. 《Pharmacotherapy》1994,14(5):509-513
Study Objective . To investigate the effect of simultaneously administered didanosine (ddI) on the absorption of a single dose of itraconazole. Design . Randomized, crossover, unblinded single-dose pharmacokinetic study in healthy volunteers. Comparisons of itraconazole alone and itraconazole with simultaneous ddI were performed on days 1 and 15. Setting . A university medical center. Patients . Seven healthy men and women. Six subjects (86%) completed the study; one was removed due to the development of a rash. Interventions . Volunteers received a single 200-mg oral dose of itraconazole or itraconazole with concomitant oral ddI 300 mg (two 150-mg tablets) dispersed in 240 ml water. Each regimen was separated by a 2-week washout period. Serum samples were obtained frequently for 12 hours after the dose. Measurements and Main Results . Concentrations of itraconazole were determined using a microbiologic assay. Individual concentrations in serum versus time data were evaluated by linear regression analysis. Peak serum concentration and time to peak were determined by visual inspection of each individual's serum concentration-time curve. A mean ± SD peak serum itraconazole concentration of 0.90 ± 0.30 μg/ml was observed at 3.0 ± 0.7 hours when itraconazole was administered alone, compared with undetectable levels in all patients during therapy with ddI. Conclusions . Simultaneous oral administration of ddI significantly decreases absorption of itraconazole. These drugs should not be administered concurrently. 相似文献
30.